Literature DB >> 23816543

Association of the Val66Met polymorphism of the BDNF gene with primary cranial-cervical dystonia patients from South-west China.

Yongping Chen1, Wei Song, Jing Yang, Ke Chen, Rui Huang, Bi Zhao, Bei Cao, Jeanmarc Burgunder, Hui-Fang Shang.   

Abstract

BACKGROUND: The etiology of primary dystonia remains unclear. Recent genetic studies suggest that the Val66Met polymorphism of the BDNF gene is a genetic modifier in cranial-cervical dystonia in Caucasians. However, the finding is not consistent. PATIENTS AND METHODS: A total of 193 patients with primary cranial-cervical dystonia from the Department of Neurology, West China Hospital of Sichuan University was included. From the same region, 216 healthy individuals were recruited as a control group. The Val66Met SNP was identified by polymerase chain reaction-restriction fragment length polymorphism.
RESULTS: In the present study, cervical dystonia (59.59%) was the most common type of primary cranial-cervical dystonia. No significant difference was found in the genotype and minor allele frequencies between all patients and controls, between cervical dystonia patients and controls, and between craniocervical dystonia patients and controls. However, significant differences were found in the genotype and minor allele frequencies of Val66Met SNP between blepharospasm (BSP) patients and controls (P=0.0080 and P=0.0042, respectively), and between BSP patients and patients with craniocervical derived from BSP (P=0.0010 and P=0.0002, respectively).
CONCLUSION: Minor allele "A" of BDNF Val66Met SNP may increase the risk for developing BSP and may be a protective factor for preventing BSP progressing to craniocervical dystonia. More association studies involving a larger number of participants are needed to confirm the present findings.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BDNF gene; Primary dystonia; Vel66Met polymorphism

Mesh:

Substances:

Year:  2013        PMID: 23816543     DOI: 10.1016/j.parkreldis.2013.06.004

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

1.  BDNF rs6265 (Val66Met) Polymorphism as a Risk Factor for Blepharospasm.

Authors:  Vasileios Siokas; Dimitrios Kardaras; Athina-Maria Aloizou; Ioannis Asproudis; Konstadinos G Boboridis; Eleni Papageorgiou; Georgios M Hadjigeorgiou; Evangelia E Tsironi; Efthimios Dardiotis
Journal:  Neuromolecular Med       Date:  2018-12-05       Impact factor: 3.843

2.  Association of TOR1A and GCH1 Polymorphisms with Isolated Dystonia in India.

Authors:  Subhajit Giri; Arunibha Ghosh; Shubhrajit Roy; Charulata Savant Sankhla; Shyamal Kumar Das; Kunal Ray; Jharna Ray
Journal:  J Mol Neurosci       Date:  2020-07-13       Impact factor: 3.444

Review 3.  The neurobiological basis for novel experimental therapeutics in dystonia.

Authors:  Anthony M Downs; Kaitlyn M Roman; Simone A Campbell; Antonio Pisani; Ellen J Hess; Paola Bonsi
Journal:  Neurobiol Dis       Date:  2019-07-04       Impact factor: 5.996

Review 4.  The Role of TOR1A Polymorphisms in Dystonia: A Systematic Review and Meta-Analysis.

Authors:  Vasileios Siokas; Efthimios Dardiotis; Evangelia E Tsironi; Georgios Tsivgoulis; Dimitrios Rikos; Maria Sokratous; Stylianos Koutsias; Konstantinos Paterakis; Georgia Deretzi; Georgios M Hadjigeorgiou
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

Review 5.  Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update.

Authors:  Hongying Ma; Jian Qu; Liangjun Ye; Yi Shu; Qiang Qu
Journal:  Front Neurol       Date:  2021-03-29       Impact factor: 4.003

Review 6.  Risk Factor Genes in Patients with Dystonia: A Comprehensive Review.

Authors:  Vasileios Siokas; Athina-Maria Aloizou; Zisis Tsouris; Amalia Michalopoulou; Alexios-Fotios A Mentis; Efthimios Dardiotis
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-01-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.